Plasma cytomegalovirus (CMV) DNA load predicts CMV disease and survival in AIDS patients

Journal of Clinical Investigation

Volumn 101, Issue 2, 1998, Pages 497-502

  Spector, Stephen A ^a   Wong, Rodney ^b   Hsia, Karen ^a   Pilcher, Marshall ^a   Stempien, Mary Jean ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Roche Global Development   (United States)

Author keywords

CMV in AIDS; CMV load and survival in AIDS; CMV retinitis; Markers for prevention of CMV disease in AIDS; Quantitative CMV PCR

Indexed keywords

CD4 ANTIGEN; GANCICLOVIR; VIRUS DNA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS; DNA DETERMINATION; DRUG EFFICACY; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MORTALITY; PREDICTION; PRIORITY JOURNAL; QUANTITATIVE DIAGNOSIS; SURVIVAL;

EID: 0032518617     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI1101     Document Type: Article

References (29)

1. Bloom, J.N., and A.G. Palestine. 1988. The diagnosis of cytomegalovirus retinitis. Ann. Intern. Med. 109:963-969.
2. Drew, W.L. 1992. Cytomegalovirus infection in patients with AIDS. Clin. Infect. Dis. 14:608-615.
3. + lymphocyte counts, and the development of AIDS in HIV-1-infected hemophiliac patients. Clin. Exp. Immunol. 88:6-9.
4. Detels, R., C.T. Leach, K. Hennessey, Z. Liu, B.R. Visscher, J.D. Cherry, and J.V. Giorgi. 1994. Persistent cytomegalovirus infection of semen increases risk of AIDS. J. Infect. Dis. 169:766-768.
5. Frenkel, L.D., S. Gaur, M. Tsolia, R. Scudder, R. Howell, and H. Kesarwala. 1990. Cytomegalovirus infection in children with AIDS. Rev. Infect. Dis. 12:S820-S826.
6. Crumpacker, C.S. 1996. Ganciclovir. N. Engl. J. Med. 335:721-729.
7. Palestine, A.G., M.A. Polis, M.D. De Smet, B.F. Baird, J. Falloon, J.A. Kovacs, R.T. Davey, J.J. Zurlo, K.M. Zunich, and M. Davis. 1991. A randomized, controlled trial of foscarnet in the treatment of cytomegalovirus retinitis in patients with AIDS. Ann. Intern. Med. 115:665-673.
8. Lalezari, J.P., R.J. Stagg, B.D. Kupperman, G.N. Holland, F. Kramer, D.V. Ives, M. Youle, M.R. Robinson, W.L. Drew, and H.S. Jaffe. 1997. Intravenous cidofovir for peripheral cytomegalovirus retinitis in patients with AIDS. Ann. Intern. Med. 126:257-263.
9. Studies of Ocular Complications of AIDS Research Group in Collaboration with the AIDS Clinical Trials Group. 1996. Combination of foscarnet and ganciclovir therapy vs. monotherapy for the treatment of relapsed cytomegalovirus retinitis in patients with AIDS. Arch. Ophthalmol. 114:23-32.
10. Spector, S.A., G.F. McKinley, J.P. Lalezari, T. Samo, R. Andruczk, S. Follansbee, P.D. Sparti, D.V. Havlir, G. Simpson, W. Buhles, et al, for the Roche Cooperative Oral Ganciclovir Study Group. 1996. Oral ganciclovir for the prevention of cytomegalovirus disease in persons with AIDS. N. Engl. J. Med. 334:1491-1497.
11. Feinberg, J., D. Cooper, and S. Hurwitz. 1996. Phase III international study of valaciclovir (VACV) for cytomegalovirus (CMV) prophylaxis in patients with advanced HIV disease. Abstracts of the XI International Conference on AIDS. July 7-12. Vancouver, Canada. Creative Direction & Design Signals, Design Group, Inc. Vancouver, Canada, p. 225. Abstract Th. B300.
12. Gerna, G., F. Baldanti, M. Zavattoni, A. Sarasini, E. Percivalle, and M.G. Revello. 1992. Monitoring of ganciclovir sensitivity of multiple human cytomegalovirus strains coinfecting blood of an AIDS patient by an immediate-early antigen plaque assay. Antivir. Res. 19:333-345.
13. Rasmussen, L., S. Morris, D. Zipeto, J. Fessel, R. Wolitz, A. Dowling, and T.C. Merigan. 1995. Quantitation of human cytomegalovirus DNA from peripheral blood cells of human immunodeficiency virus-infected patients could predict cytomegalovirus retinitis. J. Infect. Dis. 171:177-182.
14. Spector, S.A., R. Merrill, D. Wolf, and W.M. Dankner. 1992. Detection of human cytomegalovirus in plasma of AIDS patients during acute visceral disease by DNA amplification. J. Clin. Microbiol. 30:2359-2365.
15. Shinkai, M., S.A. Bozzette, W. Powderly, P. Frame, and S.A. Spector. 1997. Utility of urine and leukocyte cultures and plasma DNA PCR for identification of AIDS patients at risk for developing human cytomegalovirus disease. J. Infect. Dis. 175:302-308.
16. Bowen, E.F., P. Wilson, A. Cope, C. Sabin, P. Griffiths, C. Davey, M. Johnson, and V. Emery. 1996. Cytomegalovirus retinitis in AIDS patients: influence of cytomegaloviral load on response to ganciclovir, time to recurrence and survival. AIDS (Lond.). 10:1515-1520.
17. Boom, R., C.J.A. Sol, M.M. Salimans, C.L. Jansen, P.M. Wertheim-van Dillen, and J. van der Noordaa. 1990. Rapid and simple method for purification of nucleic acids. J. Clin. Microbiol. 28:495-503.
18. Shinkai, M., and S.A. Spector. 1995. Quantitation of human cytomegalovirus (HCMV) DNA in cerebrospinal fluid by competitive PCR in AIDS patients with different HCMV central nervous system diseases. Scand. J. Infect. Dis. 27:559-561.
19. Erice, A., C. Crumpacker, W. Britt, W.L. Drew, R. Hillam, S. Kao, I. Kolberg, M. Landry, N. Lurain, J. Manischewitz, et al. 1996. Quantitation of cytomegalovirus (CMV) load in blood fractions of patients with AIDS; a complete study of different laboratory methods. Abstracts of the 3rd Conference, Retroviruses and Opportunistic Infections, Session 25. Jan 28-Feb 1. Washington, D.C. Infectious Diseases Society of America for the Foundation for Retrovirology and Human Health, Alexandria, VA, p. 83. Abstract 166.
20. Kaplan, E.L., and P. Meier. 1958. Nonparametric estimation from incomplete observations. J. Am. Stat. Assoc. 53:457-481.
21. Cox, D.R., and D. Oakes. 1984. Analysis of Survival Data, Chapman and Hall, London.
22. Mellors, J.W., C.R. Rinaldo, P. Gupta, R.M. White, J.A. Todd, and L.A. Kingsley. 1996. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science. 272:1167-1170.
23. Bowen, E.F., P.F. Wilson, D.C. Johnson, P.D. Griffiths, and V.C. Emery. 1996. Use of PCR to detect asymptomatic CMV retinitis. Abstracts of the XI International Conference on AIDS. July 7-12. Vancouver, Canada. Creative Direction & Design Signals, Design Group, Inc. Vancouver, Canada, p. 218. Abstract Th. A. 394.
24. Dodt, K.K., P.H. Jacobsen, B. Hofmann, C. Meyer, H.J. Kolmos, P. Skinhoj, B. Norrild, and L. Mathiesen. 1997. Development of cytomegalovirus (CMV) disease may be predicted in HIV-infected patients by CMV polymerase chain reaction and the antigenemia test. AIDS (Lond.). 11:F21-F28.
25. Saltzman, R.L., M.R. Quirk and M.C. Jordan. 1992. High levels of circulating cytomegalovirus DMA reflect visceral organ disease in viremic immunosuppressed patients other than marrow recipients. J. Clin. Invest. 90:1832-1838.
26. Aspin, M.M., G.M. Gallez-Hawkins, T.D. Giugni, B. Tegtmeier, D.J. Lang, G.M. Schmidt, S.J. Forman, and J.A. Zaia. 1994. Comparison of plasma PCR and bronchoalveolar lavage fluid culture for detection of cytomegalovirus infection in adult bone marrow transplant recipients. J. Clin. Microbiol. 32: 2266-2269.
27. Brown, F., I. Arum, G. Francis, M. Patel, and S. Malcolm. 1997. Ganciclovir prodrug (RS-79070) - multiple dose, dose-ranging study with effect of fond. Abstracts of the 4th Conference on Retroviruses and Opportunistic Infections. Session 88. Jan 22-26. Washington, D.C. IDSA Foundation for Retrovirology and Human Health. Alexandria, VA, p. 209. Abstract LB19.
28. Wang, L.H., R. Peck, P.Q. Chan, M. Youle, J. Eaves, and A. Bye. 1997. A phase I tolerability and pharmacokinetic (PK) trial of 1263W94, a novel anti-HCMV agent, in HIV-infected volunteers. Abstracts of the 4th Conference on Retroviruses and Opportunistic Infections. Session 69. Jan 22-26. Washington, D.C. IDSA Foundation for Retrovirology and Human Health. Alexandria, VA, p. 189. Abstract 674.
29. Lalezari, J., L. Drew, C. Jordan, P. Jensen, A. Moe, L. Reynolds, S. Mohanty, A. Cross, and L. Dunkle. 1997. In vivo anti-CMV activity and safety of oral lobucavir in HIV-infected patients. Abstracts of the 4th Conference on Retroviruses and Opportunistic Infections. Session 31. Jan 22-26. Washington, D.C. IDSA Foundation for Retrovirology and Human Health. Alexandria, VA, p. 220. 301.